Skip to content

The effect of chamomilla cream on wound healing and pain of episiotomy in Primiparous women

The effect of chamomilla cream on wound healing and pain of episiotomy in Primiparous women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013051413336N1
Enrollment
106
Registered
2013-12-25
Start date
2013-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound healing of episiotomy , pain of episiotomy. Disruption of perineal obstetric wound

Interventions

Intervention 1: In the intervention group, chamomile cream 1/3 percent of the combined value is Cold Cream with Chamomile has been used. Units of study Chamomile cream the size of a finger is placed o
Treatment - Drugs
Placebo
In the intervention group, chamomile cream 1/3 percent of the combined value is Cold Cream with Chamomile has been used. Units of study Chamomile cream the size of a finger is placed on the sutures so
In the control group of placebo cream containing simple base cream (Cold Cream) are used. Units of study placebo cream the size of a finger is placed on the sutures so that the wound is completely cov

Sponsors

Research Council of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: nulliparous women aged 18-35 years old living in the city of Mashhad, Iran; at least having the ability to read and write; living with his wife's; body mass index ranging from 19/8-30; non-smoking and no drug dependence; no history of disease impaired wound healing; not using drugs effecting on wound healing; single fetal cephalic; lack of symptomatic infections of the vagina and vulva (the infectious discharge, itching, burning); low blood, anal lesions; vulva and perineum on admission; and rupture of the fetal sac up to 12 hours before the start of pains; lack of stricture restriction pelvic; embryos is vital; the lack of apparent anomalies in the newborn. No rectocel, cystocele severe (grade 2 or higher), wall or mass in the vaginal; no history of obstetric complications, use of acetaminophen suppository in 6 hours before delivery; no history of vaginal reconstructive surgery on the Vagina and urethra Exclusion criteria: there interfere with the progress of labor; prolonged second stage of labor longer than 2 hours; delivery devices (vacuum, forceps); delivered via cesarean section; extend the length of the incision or there tear except episiotomy tear; infant hospitalization in the NICU; abnormal vaginal bleeding; shoulder dystocia (leading to the maneuvers other than Robert Mack); manual removal of placenta; hematoma; having intercourse to the end of the study (15 days postpartum); curettage procedure the first 24 hours after birth; the third stage of labor longer than 30 minutes; the occurrence of an adverse event at 15 days postpartum; no need for episiotomy; not use the cream on a regular; puerperal fever; complications resulting from the use of chamomile cream.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain of episiotomy. Timepoint: Immediately before the intervention to 2 weeks after intervention. Method of measurement: McGill Pain Questionnaire short.;Wound healing of episiotomy. Timepoint: First Day of episiotomy repair to 14 days. Method of measurement: Scale reeda.

Secondary

MeasureTime frame
The rate of pain episiotomy. Timepoint: Immediately prior to the 2-week after the start of the intervention intervention. Method of measurement: Questionnaire McGill Pain short.;The rate of wound healing of episiotomy. Timepoint: First Day of episiotomy repair to 14 days. Method of measurement: Scale reeda.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Aradmehr

Mashhad University of Medical Sciences

maryam.aradmehr@yahoo.com

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026